_id
691314f8ccc777a4e85d8032
Ticker
MENS
Name
Jyong Biotech Ltd. Ordinary Shares
Exchange
NASDAQ
Address
No. 95, Xintai 5th Road, New Taipei City, Taiwan, 221
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://jyongbio.com
Description
Jyong Biotech Ltd., a science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops MCS-2 for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.
Last Close
4.09
Volume
640673
Current Price
3.81
Change
-0.54
Last Updated
2026-01-05T10:21:16.265Z
Image
-
Ipo Date
2025-06-17T00:00:00.000Z
Market Cap
644714816
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.89
Sentiment Sources
2
Current Quarter
2024-12-31
Revenue
-
Cost Of Revenue
58000
Gross Profit
-58000
Operating Expenses
552.5
Operating Income
-552.5
Interest Expense
-
Pretax Income
-846.5
Net Income
-846.5
Eps
-0.011828077186412732
Dividends Per Share
-
Shares Outstanding
76027696
Income Tax Expense
-
EBITDA
-523.5
Operating Margin
-
Total Other Income Expense Net
-294
Cash
98000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
206000
Property Plant Equipment
3186000
Total Assets
6366000
Payables
3000
Short Term Debt
7441000
Long Term Debt
10678000
Total Liabilities
42885000
Equity
-36519000
Bs_currency_symbol
USD
Depreciation
29
Change In Working Capital
163
Cash From Operations
-913000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
848000
Net Change In Cash
2000
Cf_currency_symbol
-
PE
-
PB
-0.007466531668446562
ROE
0.0023179714669076374
ROA
-0.013297203895695883
FCF
-913000
Fcf Percent
-
Piotroski FScore
0
Health Score
23
Deep Value Investing Score
1
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
3
Net Net Investing Score
0.5
Quality Investing Score
1
Value Investing Score
1
Quarters > 0 > quarter
2024-12-31
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
58000
Quarters > 0 > income Statement > gross Profit
-58000
Quarters > 0 > income Statement > operating Expenses
552.5
Quarters > 0 > income Statement > operating Income
-552.5
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-846.5
Quarters > 0 > income Statement > net Income
-846.5
Quarters > 0 > income Statement > eps
-0.011828077186412732
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
71567
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-523.5
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-294
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
98000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
206000
Quarters > 0 > balance Sheet > property Plant Equipment
3186000
Quarters > 0 > balance Sheet > total Assets
6366000
Quarters > 0 > balance Sheet > payables
3000
Quarters > 0 > balance Sheet > short Term Debt
7441000
Quarters > 0 > balance Sheet > long Term Debt
10678000
Quarters > 0 > balance Sheet > total Liabilities
42885000
Quarters > 0 > balance Sheet > equity
-36519000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-846.5
Quarters > 0 > cash Flow > depreciation
29
Quarters > 0 > cash Flow > change In Working Capital
163
Quarters > 0 > cash Flow > cash From Operations
-913000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
848000
Quarters > 0 > cash Flow > net Change In Cash
2000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.011828077186412732
Quarters > 0 > ratios > PB
-0.007466531668446562
Quarters > 0 > ratios > ROE
0.0023179714669076374
Quarters > 0 > ratios > ROA
-0.013297203895695883
Quarters > 0 > ratios > FCF
-913000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
23
Quarters > 1 > quarter
2024-09-30
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
552.5
Quarters > 1 > income Statement > operating Income
-552.5
Quarters > 1 > income Statement > interest Expense
293
Quarters > 1 > income Statement > pretax Income
-846.5
Quarters > 1 > income Statement > net Income
-846.5
Quarters > 1 > income Statement > eps
-0.011828077186412732
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
71567
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-523.5
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-294
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
98000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
206000
Quarters > 1 > balance Sheet > property Plant Equipment
3186000
Quarters > 1 > balance Sheet > total Assets
6366000
Quarters > 1 > balance Sheet > payables
3000
Quarters > 1 > balance Sheet > short Term Debt
7441000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
42885000
Quarters > 1 > balance Sheet > equity
-36519000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-846.5
Quarters > 1 > cash Flow > depreciation
29
Quarters > 1 > cash Flow > change In Working Capital
163
Quarters > 1 > cash Flow > cash From Operations
-425.5
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
424
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.011828077186412732
Quarters > 1 > ratios > PB
-0.007466531668446562
Quarters > 1 > ratios > ROE
0.0023179714669076374
Quarters > 1 > ratios > ROA
-0.013297203895695883
Quarters > 1 > ratios > FCF
-425.5
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
24
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
62000
Quarters > 2 > income Statement > gross Profit
-62000
Quarters > 2 > income Statement > operating Expenses
475.5
Quarters > 2 > income Statement > operating Income
-475.5
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-663
Quarters > 2 > income Statement > net Income
-663
Quarters > 2 > income Statement > eps
-0.00926404627831263
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
71567
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-444.5
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-187.5
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
96000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
200000
Quarters > 2 > balance Sheet > property Plant Equipment
3338000
Quarters > 2 > balance Sheet > total Assets
6440000
Quarters > 2 > balance Sheet > payables
9000
Quarters > 2 > balance Sheet > short Term Debt
7622000
Quarters > 2 > balance Sheet > long Term Debt
9670000
Quarters > 2 > balance Sheet > total Liabilities
41366000
Quarters > 2 > balance Sheet > equity
-34926000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-663
Quarters > 2 > cash Flow > depreciation
31
Quarters > 2 > cash Flow > change In Working Capital
-906.5
Quarters > 2 > cash Flow > cash From Operations
-2711000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
1142000
Quarters > 2 > cash Flow > net Change In Cash
99000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.00926404627831263
Quarters > 2 > ratios > PB
-0.007807085552310599
Quarters > 2 > ratios > ROE
0.00189829926129531
Quarters > 2 > ratios > ROA
-0.01029503105590062
Quarters > 2 > ratios > FCF
-2711000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
23
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
475.5
Quarters > 3 > income Statement > operating Income
-475.5
Quarters > 3 > income Statement > interest Expense
221
Quarters > 3 > income Statement > pretax Income
-663
Quarters > 3 > income Statement > net Income
-663
Quarters > 3 > income Statement > eps
-0.00926404627831263
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
71567
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-444.5
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-187.5
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
96000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
200000
Quarters > 3 > balance Sheet > property Plant Equipment
3338000
Quarters > 3 > balance Sheet > total Assets
6440000
Quarters > 3 > balance Sheet > payables
9000
Quarters > 3 > balance Sheet > short Term Debt
7622000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
41366000
Quarters > 3 > balance Sheet > equity
-34926000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-663
Quarters > 3 > cash Flow > depreciation
31
Quarters > 3 > cash Flow > change In Working Capital
-906.5
Quarters > 3 > cash Flow > cash From Operations
-1386.5
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
571
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.00926404627831263
Quarters > 3 > ratios > PB
-0.007807085552310599
Quarters > 3 > ratios > ROE
0.00189829926129531
Quarters > 3 > ratios > ROA
-0.01029503105590062
Quarters > 3 > ratios > FCF
-1386.5
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
23
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
120000
Annuals > 0 > income Statement > gross Profit
-120000
Annuals > 0 > income Statement > operating Expenses
2056000
Annuals > 0 > income Statement > operating Income
-2056000
Annuals > 0 > income Statement > interest Expense
1035000
Annuals > 0 > income Statement > pretax Income
-3019000
Annuals > 0 > income Statement > net Income
-3019000
Annuals > 0 > income Statement > eps
-0.03970922848388864
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
76027667
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-1864000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-963000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
98000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
206000
Annuals > 0 > balance Sheet > property Plant Equipment
3186000
Annuals > 0 > balance Sheet > total Assets
6366000
Annuals > 0 > balance Sheet > payables
3000
Annuals > 0 > balance Sheet > short Term Debt
7441000
Annuals > 0 > balance Sheet > long Term Debt
10678000
Annuals > 0 > balance Sheet > total Liabilities
42885000
Annuals > 0 > balance Sheet > equity
-36519000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-3019000
Annuals > 0 > cash Flow > depreciation
120000
Annuals > 0 > cash Flow > change In Working Capital
-1486000
Annuals > 0 > cash Flow > cash From Operations
-3624000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
1990000
Annuals > 0 > cash Flow > net Change In Cash
-1641000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.03970922848388864
Annuals > 0 > ratios > PB
-7.0991632977354255
Annuals > 0 > ratios > ROE
8.266929543525288
Annuals > 0 > ratios > ROA
-47.423814011938425
Annuals > 0 > ratios > FCF
-3624000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
22
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
127000
Annuals > 1 > income Statement > gross Profit
-127000
Annuals > 1 > income Statement > operating Expenses
2797000
Annuals > 1 > income Statement > operating Income
-2797000
Annuals > 1 > income Statement > interest Expense
757000
Annuals > 1 > income Statement > pretax Income
-4400000
Annuals > 1 > income Statement > net Income
-4400000
Annuals > 1 > income Statement > eps
-0.05787366854226896
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
76027667
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-3516000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-1603000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
177000
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
1839000
Annuals > 1 > balance Sheet > property Plant Equipment
3544000
Annuals > 1 > balance Sheet > total Assets
8248000
Annuals > 1 > balance Sheet > payables
2000
Annuals > 1 > balance Sheet > short Term Debt
8102000
Annuals > 1 > balance Sheet > long Term Debt
8520000
Annuals > 1 > balance Sheet > total Liabilities
42321000
Annuals > 1 > balance Sheet > equity
-34073000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-4400000
Annuals > 1 > cash Flow > depreciation
127000
Annuals > 1 > cash Flow > change In Working Capital
1118000
Annuals > 1 > cash Flow > cash From Operations
-2601000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
95000
Annuals > 1 > cash Flow > cash From Financing
2028000
Annuals > 1 > cash Flow > net Change In Cash
-532000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.05787366854226896
Annuals > 1 > ratios > PB
-7.608791256126552
Annuals > 1 > ratios > ROE
12.913450532679835
Annuals > 1 > ratios > ROA
-53.34626576139671
Annuals > 1 > ratios > FCF
-2601000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
24
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
122000
Annuals > 2 > income Statement > gross Profit
-122000
Annuals > 2 > income Statement > operating Expenses
2829000
Annuals > 2 > income Statement > operating Income
-2829000
Annuals > 2 > income Statement > interest Expense
765000
Annuals > 2 > income Statement > pretax Income
-6630000
Annuals > 2 > income Statement > net Income
-6630000
Annuals > 2 > income Statement > eps
-0.08720509600800982
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
76027667
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-5742000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-3801000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
718000
Annuals > 2 > balance Sheet > short Term Investments
94000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
2463000
Annuals > 2 > balance Sheet > property Plant Equipment
5999000
Annuals > 2 > balance Sheet > total Assets
8745000
Annuals > 2 > balance Sheet > payables
4000
Annuals > 2 > balance Sheet > short Term Debt
7818000
Annuals > 2 > balance Sheet > long Term Debt
6318000
Annuals > 2 > balance Sheet > total Liabilities
38376000
Annuals > 2 > balance Sheet > equity
-29631000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-6630000
Annuals > 2 > cash Flow > depreciation
123000
Annuals > 2 > cash Flow > change In Working Capital
2937000
Annuals > 2 > cash Flow > cash From Operations
-2971000
Annuals > 2 > cash Flow > capital Expenditures
246000
Annuals > 2 > cash Flow > cash From Investing
1392000
Annuals > 2 > cash Flow > cash From Financing
3333000
Annuals > 2 > cash Flow > net Change In Cash
1723000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.08720509600800982
Annuals > 2 > ratios > PB
-8.749429464749756
Annuals > 2 > ratios > ROE
22.375215146299485
Annuals > 2 > ratios > ROA
-75.8147512864494
Annuals > 2 > ratios > FCF
-3217000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
121000
Annuals > 3 > income Statement > gross Profit
-121000
Annuals > 3 > income Statement > operating Expenses
2404000
Annuals > 3 > income Statement > operating Income
-2404000
Annuals > 3 > income Statement > interest Expense
835000
Annuals > 3 > income Statement > pretax Income
-4198000
Annuals > 3 > income Statement > net Income
-4198000
Annuals > 3 > income Statement > eps
-0.05521674103191934
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
76027667
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-3241000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-1794000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
551000
Annuals > 3 > balance Sheet > short Term Investments
1834000
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
2648000
Annuals > 3 > balance Sheet > property Plant Equipment
6776000
Annuals > 3 > balance Sheet > total Assets
9432000
Annuals > 3 > balance Sheet > payables
46000
Annuals > 3 > balance Sheet > short Term Debt
5183000
Annuals > 3 > balance Sheet > long Term Debt
6260000
Annuals > 3 > balance Sheet > total Liabilities
32757000
Annuals > 3 > balance Sheet > equity
-23325000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-4198000
Annuals > 3 > cash Flow > depreciation
122000
Annuals > 3 > cash Flow > change In Working Capital
1243000
Annuals > 3 > cash Flow > cash From Operations
-1984000
Annuals > 3 > cash Flow > capital Expenditures
137000
Annuals > 3 > cash Flow > cash From Investing
-1307000
Annuals > 3 > cash Flow > cash From Financing
-1383000
Annuals > 3 > cash Flow > net Change In Cash
-4607000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.05521674103191934
Annuals > 3 > ratios > PB
-11.11487007374062
Annuals > 3 > ratios > ROE
17.9978563772776
Annuals > 3 > ratios > ROA
-44.50805767599661
Annuals > 3 > ratios > FCF
-2121000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
28
Valuation > metrics > PE
-0.011828077186412732
Valuation > metrics > PB
-0.007466531668446562
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
0.0023179714669076374
Profitability > metrics > ROA
-0.41092233009708734
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-1.7105263157894737
Risk > final Score
23
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.027673293927995703
Liquidity > metrics > Quick Ratio
0.027673293927995703
Liquidity > final Score
11
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
22
Prev Risks > 1
21
Prev Risks > 2
21
Prev Liquidities > 0
11
Prev Liquidities > 1
11
Prev Liquidities > 2
11
Updated At
2026-01-20T22:11:40.260Z
Earnings History > 0 > period
2025-03-31
Earnings History > 0 > report Date
2025-04-23
Earnings History > 0 > date
2025-03-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.02
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.02
Earnings History > 0 > surprise Percent
-
Jyong Biotech Ltd., a science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops MCS-2 for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AVirginia Tech men's basketball's stock report after win over Notre Dame MSN
Read more →Showing 2 of 10
(Last Updated 2024-12-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Jyong Biotech Ltd. Ordinary Shares
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-03-31
EPS Actual
-0.02
EPS Estimate
0
EPS Difference
-0.02
Surprise Percent
0%
(Last Updated 2024-12-31)
(Last Updated 2024-12-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-12-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-12-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.